Skip to Main Content
ADVERTISEMENT
SCROLL TO CONTINUE WITH CONTENT



Property Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes
Advertisement
Mayo Clinic Proceedings: Innovations, Quality & Outcomes
MCP Digital Health Home
Close
  • Home
  • Articles & Issues
    • Back
    • COVID Articles In Press
    • Issue In Progress
    • Current Issue
    • List of Issues
  • Visual and Interactive
    • Back
    • Author Interview Video Library
  • Collections
    • Back
    • Case Reports
    • Commentaries
    • Editorials
  • For Authors
    • Back
    • Submit a Manuscript 
    • Author Information
    • Open Access Options 
    • Permissions
    • Researcher Academy
  • Journal Info
    • Back
    • About the Journal
    • Contact Editorial Office
    • Editorial Board
    • Reprints 
    • New Content Alerts
  • Companion Titles
    • Back
    • Mayo Clinic Proceedings 
    • MCP: Digital Health 
  • Mayo Clinic
    • Back
    • Home 
    • Mayo Clinic Resources
    • Online Services for Medical Professionals 
    • Continuing Medical Education 
Advanced searchSave search

Please enter a term before submitting your search.

Ok
  • Submit
  • Log in
  • Register
  • Log in
    • Submit
    • Log in
Skip menu

    Login to your account

    Show
    Forgot password?
    Don’t have an account?
    Create a Free Account

    If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password

    If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password

    Cancel
    x

    Filter:

    Filters applied

    • Case Reports

    Article Type

    • Case Reports37
    • Rapid Communication1

    Publication Date

    • Last 2 Years5
    • Last 5 Years33
    Please choose a date range between 2017 and 2021.

    Author

    • Gorny, Krzysztof R2
    • Hesley, Gina K2
    • Hogan, Breann M2
    • Abu Saleh, Omar M1
    • Ackermann, Ronald T1
    • Agbasi, Nneoma1
    • Ahmed, Mohamed E1
    • Ajayi, Olayinka D1
    • Al-Ghawas, Mae S1
    • Albadri, Sam T1
    • Albitar, Hasan Ahmad1
    • Albitar, Hasan Ahmad Hasan1
    • Alhammad, Reem M1
    • Almodallal, Yahya1
    • Amin, Alpesh1
    • Anderson, Jason H1
    • Andrews, Jack R1
    • Assad, Ayman Haj1
    • Avila, Daniele1
    • Becker, Tara L1
    • Berbari, Hadi E1
    • Bhatt, Shubhang K1
    • Bhushan, Samay1
    • Bierle, Dennis Michael1
    • Block, Shanna1

    Journal

    • Mayo Clinic Proceedings: Innovations, Quality & Outcomes 38

    Keyword

    • magnetic resonance imaging11
    • MRI11
    • computed tomography6
    • CT6
    • intravenous4
    • IV4
    • FDA3
    • Food and Drug Administration3
    • TTE3
    • C-reactive protein2
    • coronavirus disease 20192
    • COVID-192
    • CRP2
    • CSF2
    • EF2
    • PD-12
    • RV2
    • transthoracic echocardiography2
    • ACR1
    • ADR1
    • ADT1
    • AICA1
    • AL1
    • AMC1
    • AR1

    Access Filter

    • Open Access

    Case Reports

    38 Results
    Subscribe to collection
    • Export
      • PDF
      • Citation

    Please select at least one article in order to proceed.

    Ok
    FilterHide Filter
    • Case report
      Open Access

      Chromogenic Factor X Assay for Monitoring Warfarin Anticoagulation in a Child With a Prosthetic Mitral Valve

      Mayo Clinic Proceedings: Innovations, Quality & Outcomes
      Vol. 5Issue 5p811–816Published online: August 10, 2021
      • Jacob R. Greenmyer
      • Talha Niaz
      • Mira A. Kohorst
      • Elizabeth H. Stephens
      • Jason H. Anderson
      Cited in Scopus: 0
      • Preview Hide Preview
      • Download PDF
      • Export Citation
        Mechanical mitral valve replacement in infants and young children is associated with substantial morbidity and mortality. Lifelong anticoagulation is required, with all the accompanying challenges of maintaining levels in infants and children whose dietary input continually changes. Even with careful control of all aspects that can perturb the coagulation cascade, these patients have a substantial lifelong risk of thrombotic and hemorrhagic complications that can also affect the durability of the valve.
        Chromogenic Factor X Assay for Monitoring Warfarin Anticoagulation in a Child With a Prosthetic Mitral Valve
      • Case report
        Open Access

        Successful Treatment of Pembrolizumab-Induced Severe Capillary Leak Syndrome and Lymphatic Capillary Dysfunction

        Mayo Clinic Proceedings: Innovations, Quality & Outcomes
        Vol. 5Issue 3p670–674Published online: June 7, 2021
        • Haixia Qin
        • Brittany Vlaminck
        • Itunu Owoyemi
        • Sandra M. Herrmann
        • Nelson Leung
        • Svetomir N. Markovic
        Cited in Scopus: 0
        • Preview Hide Preview
        • Download PDF
        • Export Citation
          Although capillary leak syndrome has a high mortality rate, its trigger, diagnosis, and treatment remain a challenge to clinicians because of the poor understanding of its mechanism and lack of treatment guidelines. With the extended use of immune checkpoint inhibitors in modern oncology, immune checkpoint inhibitor–associated immune-related adverse events have also expanded. We present a case of pembrolizumab-induced capillary leak syndrome and lymphatic capillary dysfunction in which the patient had an excellent clinical response to a tailored treatment strategy.
          Successful Treatment of Pembrolizumab-Induced Severe Capillary Leak Syndrome and Lymphatic Capillary Dysfunction
        • Case report
          Open Access

          Glycemic Outcomes of Second-Line Diabetes Drug Choice in a Real-World Population

          Mayo Clinic Proceedings: Innovations, Quality & Outcomes
          Vol. 5Issue 3p675–681Published online: May 26, 2021
          • Amisha Wallia
          • Matthew J. O’Brien
          • David T. Liss
          • Raymond H. Kang
          • Andrew J. Cooper
          • Amy Gilmer
          • and others
          Cited in Scopus: 0
          • Preview Hide Preview
          • Download PDF
          • Export Citation
            Hypoglycemia and acute metabolic complications (AMCs; ketoacidosis, hyperosmolarity, and coma) are glycemic outcomes that have high cost and high morbidity; these outcomes must be taken into consideration when choosing initial second-line therapy after metformin. We conducted a retrospective cohort study analyzing national administrative data from adults with type 2 diabetes mellitus who started a second-line diabetes medication (sulfonylureas [SFUs], thiazolidinediones [TZDs], glucagon-like peptide 1 [GLP-1] agonists, dipeptidyl peptidase 4 [DPP-4] inhibitors, basal insulin, or sodium-glucose contransporter 2 [SGLT-2] inhibitors) between April 1, 2011 and September 30, 2015 (N=43,288) and compared rates of hypoglycemia and AMCs.
          • Case report
            Open Access

            Management of Hypertriglyceridemia-Induced Acute Pancreatitis in a Nondiabetic Patient

            Mayo Clinic Proceedings: Innovations, Quality & Outcomes
            Vol. 5Issue 2p520–524Published online: April 7, 2021
            • Jamie M. Reed
            • Breann M. Hogan
            • Navine Nasser-Ghodsi
            • Conor G. Loftus
            Cited in Scopus: 0
            • Preview Hide Preview
            • Download PDF
            • Export Citation
              Treatment strategies for hypertriglyceridemia-induced acute pancreatitis are not well defined in the current literature or guidelines. One therapeutic option is an insulin infusion accompanied by a dextrose infusion to avoid hypoglycemia. The purpose of this case report is to highlight dosing considerations for dextrose infusions in nondiabetic patients. We describe a case of hypertriglyceridemia-induced acute pancreatitis in a 34-year-old nondiabetic woman treated with a reduced-dose insulin infusion that was complicated by hypoglycemic episodes requiring dextrose infusion titrations.
              Management of Hypertriglyceridemia-Induced Acute Pancreatitis in a Nondiabetic Patient
            • Case report
              Open Access

              EVALI: A Mimicker of COVID-19

              Mayo Clinic Proceedings: Innovations, Quality & Outcomes
              Vol. 5Issue 3p682–687Published online: March 29, 2021
              • Mitchell M. Pitlick
              • Daenielle K. Lang
              • Anne M. Meehan
              • Christopher P. McCoy
              Cited in Scopus: 0
              • Preview Hide Preview
              • Download PDF
              • Export Citation
                E-cigarette or vaping product use–associated lung injury (EVALI) is a respiratory illness that has significant overlap with the symptoms of coronavirus disease 2019 (COVID-19). In the current pandemic, diagnosis of EVALI may be delayed because of anchoring bias when patients present with symptoms consistent with COVID-19. We present 3 cases of patients who were hospitalized with a presumed diagnosis of COVID-19 but were later diagnosed with EVALI.
                EVALI: A Mimicker of COVID-19
              • Case report
                Open Access

                The Impact of COVID-19 on Volume of Inpatient Hospitalization Through General Medicine and Medicine Subspecialty Services at US Medical Centers

                Mayo Clinic Proceedings: Innovations, Quality & Outcomes
                Vol. 5Issue 2p516–519Published online: March 3, 2021
                • Justine Chinn
                • Andrew Ramirez
                • Samuel Hohmann
                • Alpesh Amin
                • Ninh T. Nguyen
                Cited in Scopus: 0
                • Preview Hide Preview
                • Download PDF
                • Export Citation
                  As the coronavirus disease 2019 pandemic continues to impact hospital systems both in the United States and throughout the world, it is important to understand how the pandemic has impacted the volume of hospital admissions. Using the Vizient Inc (Chicago, IL) clinical databases, we analyzed inpatient hospital discharges from the general medicine service and its subspecialty services including cardiology, neonatology, pulmonary/critical care, oncology, psychiatry, and neurology between December 2019 and July 2020.
                  The Impact of COVID-19 on Volume of Inpatient Hospitalization Through General Medicine and Medicine Subspecialty Services at US Medical Centers
                • Case report
                  Open Access

                  Refractory Left Focal Motor Status Epilepticus as Initial Clinical Presentation of Acute Basilar Artery Thrombosis

                  Mayo Clinic Proceedings: Innovations, Quality & Outcomes
                  Vol. 5Issue 2p511–515Published online: February 11, 2021
                  • Shubhang K. Bhatt
                  • Sara Dawit
                  • Erin M. Okazaki
                  • Katherine H. Noe
                  Cited in Scopus: 0
                  • Preview Hide Preview
                  • Download PDF
                  • Export Citation
                    Seizures are uncommon with posterior circulation strokes. They are more often associated with anterior circulation strokes, with only a limited number of cases of status epilepticus reported to be related to brain stem ischemia. The literature includes case reports of generalized tonic-clonic seizures and associated status epilepticus as an initial presentation of acute basilar artery thrombosis. However, there are only rare cases reporting focal motor seizure as status epilepticus in the setting of acute basilar artery thrombosis, an important clinical presentation that should prompt evaluation for acute brain stem ischemia.
                    Refractory Left Focal Motor Status Epilepticus as Initial Clinical Presentation of Acute Basilar Artery Thrombosis
                  • Case report
                    Open Access

                    Management of Hypertriglyceridemia-Induced Acute Pancreatitis in a Nondiabetic Patient

                    Mayo Clinic Proceedings: Innovations, Quality & Outcomes
                    Vol. 5Issue 1p230–235Published in issue: February, 2021
                    • Jamie M. Reed
                    • Breann M. Hogan
                    • Navine Nasser-Ghodsi
                    • Conor G. Loftus
                    Cited in Scopus: 0
                    • Preview Hide Preview
                    • Download PDF
                    • Export Citation
                      Hypertriglyceridemia-induced acute pancreatitis treatment strategies are not well defined in current literature or guidelines. One therapy option is an insulin infusion accompanied by a dextrose infusion to avoid hypoglycemia. The purpose of this case report is to highlight dosing considerations for dextrose infusions in nondiabetic patients. We describe a case of hypertriglyceridemia-induced acute pancreatitis in a 34-year-old nondiabetic female patient treated with a reduced-dose insulin infusion, complicated by hypoglycemic episodes requiring dextrose infusion titrations.
                      Management of Hypertriglyceridemia-Induced Acute Pancreatitis in a Nondiabetic Patient
                    • Case report
                      Open Access

                      Prosthetic Joint Infections Due to Histoplasma capsulatum: A Report of 3 Cases

                      Mayo Clinic Proceedings: Innovations, Quality & Outcomes
                      Vol. 5Issue 1p225–229Published online: January 20, 2021
                      • Hadi E. Berbari
                      • Pooja Gurram
                      • Maryam Mahmood
                      • Paul J. Deziel
                      • Randall C. Walker
                      • Raymund R. Razonable
                      Cited in Scopus: 0
                      • Preview Hide Preview
                      • Download PDF
                      • Export Citation
                        Histoplasma capsulatum causes pneumonia and multisystemic disease in humans. Musculoskeletal involvement in histoplasmosis is most often tenosynovitis and rarely septic arthritis. Even more uncommon is the involvement of prosthetic joints. Here, we report a series of 3 cases of prosthetic joint failures caused by infection due to H capsulatum. Together with a review of 4 previously reported cases, we summarize host characteristics, clinical presentation, surgical approaches, antifungal management, and outcomes of this rare orthopedic joint infection.
                      • Case report
                        Open Access

                        Efficacy of 177Lu-Dotatate Therapy in the Treatment of Recurrent Meningioma

                        Mayo Clinic Proceedings: Innovations, Quality & Outcomes
                        Vol. 5Issue 1p236–240Published online: January 13, 2021
                        • Anza Zahid
                        • Derek R. Johnson
                        • Sani H. Kizilbash
                        Cited in Scopus: 0
                        • Preview Hide Preview
                        • Download PDF
                        • Export Citation
                          A 62-year-old man presented with a history of atypical meningioma (World Health Organization grade II) and recurrent as anaplastic meningioma (World Health Organization grade III). His previous treatments included multiple surgical resections, fractionated radiation therapy, stereotactic radiosurgery, everolimus/octreotide long-acting release, bevacizumab, and hydroxyurea. Magnetic resonance imaging revealed rapid volumetric progression over the prior 9 months, with a near tripling in size from 29.9 cm3 to 80.4 cm3.
                          Efficacy of 177Lu-Dotatate Therapy in the Treatment of Recurrent Meningioma
                        • Case report
                          Open Access

                          Pulmonary Vascular Disease Due to Plasma Cell Dyscrasia

                          Mayo Clinic Proceedings: Innovations, Quality & Outcomes
                          Vol. 5Issue 1p210–218Published online: November 20, 2020
                          • Indranee Rajapreyar
                          • Joanna Joly
                          • Jose Tallaj
                          • Salpy V. Pamboukian
                          • Ayman Haj Assad
                          • Carrie Lenneman
                          • and others
                          Cited in Scopus: 0
                          • Preview Hide Preview
                          • Download PDF
                          • Export Citation
                            Pulmonary hypertension (PH) has been described in myeloproliferative disorders; monoclonal plasma cell disorder such as polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes syndrome; and plasma cell dyscrasias such as multiple myeloma and amyloidosis. We describe 4 cases of PH likely due to pulmonary vascular involvement and myocardial deposition from light chain deposition disease, amyloidosis, and multiple myeloma. On the basis of our clinical experience and literature review, we propose screening for plasma cell dyscrasia in patients with heart failure with preserved ejection fraction, unexplained PH, and hematological abnormalities.
                            Pulmonary Vascular Disease Due to Plasma Cell Dyscrasia
                          • Case report
                            Open Access

                            Timed Controlled Repeated Rotation of the CAR-170-C NXSTAGE Chronic Cartridge Hemodialysis Filter: A Novel Approach to Enabling Heparin-Free Frequent Daily Home Hemodialysis

                            Mayo Clinic Proceedings: Innovations, Quality & Outcomes
                            Vol. 5Issue 1p219–224Published online: November 7, 2020
                            • Adam Locke
                            • Margaret A. Bushey
                            • Cynthia LaCroix
                            • Patience Deardoff
                            • Macaulay Amechi Chukwukadibia Onuigbo
                            Cited in Scopus: 0
                            • Preview Hide Preview
                            • Download PDF
                            • Export Citation
                              Heparin-free hemodialysis is often warranted in postoperative states, bleeding diathesis, and critically ill patients. Conventionally, this is achieved through normal saline flushes or regional citrate anticoagulation. An 87-year-old white man with end-stage renal disease and atrial fibrillation, who was taking warfarin and using maintenance home hemodialysis (HHD) with an NxStage machine, underwent laparoscopic appendicectomy. The procedure was complicated by intra-abdominal abscess, sepsis, and tamponade from a bloody pericardial effusion.
                              Timed Controlled Repeated Rotation of the CAR-170-C NXSTAGE Chronic Cartridge Hemodialysis Filter: A Novel Approach to Enabling Heparin-Free Frequent Daily Home Hemodialysis
                            • Case report
                              Open Access

                              Progressive Monoarticular Inflammatory Arthritis Following Influenza Vaccination

                              Mayo Clinic Proceedings: Innovations, Quality & Outcomes
                              Vol. 5Issue 1p204–209Published online: November 7, 2020
                              • Laurel A. Littrell
                              • Dean F. Leslie
                              • Dennis Michael Bierle
                              • Doris E. Wenger
                              Cited in Scopus: 0
                              • Preview Hide Preview
                              • Download PDF
                              • Export Citation
                                Musculoskeletal injury is an uncommon but usually self-limited complication of vaccine administration. We present a case of progressive inflammatory monoarthritis of the shoulder characterized by bone erosion, bursitis, and severe synovitis caused by an influenza vaccine administered to the ipsilateral deltoid region. Clinical symptoms began within 2 hours of vaccination, with progressive decline in function over 6 weeks. Magnetic resonance imaging examinations performed 5 months apart demonstrated progressive erosive changes of the greater tuberosity, rotator cuff injury, and extensive enhancing synovitis of the glenohumeral joint and subacromial/subdeltoid bursa.
                                Progressive Monoarticular Inflammatory Arthritis Following Influenza Vaccination
                              • Case report
                                Open Access

                                Hereditary Angioedema Attack in Utero and Treatment of the Mother and Fetus

                                Mayo Clinic Proceedings: Innovations, Quality & Outcomes
                                Vol. 4Issue 5p595–600Published online: August 22, 2020
                                • Vesna Grivcheva-Panovska
                                • Bruno Giannetti
                                Cited in Scopus: 0
                                • Preview Hide Preview
                                • Download PDF
                                • Export Citation
                                  Hereditary angioedema (HAE), an inherited deficiency of functional C1 esterase inhibitor (C1-INH), is characterized by unpredictable recurrent episodes of painful and often disabling swelling in subcutaneous and/or submucosal tissues. We report the case of a 23-year-old woman with type I HAE who had abdominal, facial, and peripheral attacks throughout her first pregnancy. A facial HAE attack occurred at week 38 of her pregnancy, and symptoms improved after self-administration of 50 U/kg of recombinant human C1-INH (total dose, 3500 U), but soon after she had an unusual abdominal sensation.
                                  Hereditary Angioedema Attack in Utero and Treatment of the Mother and Fetus
                                • Case report
                                  Open Access

                                  A Rare Case of Prostate-Specific Antigen–Producing Metastatic Parotid Adenocarcinoma Developing Androgen Receptor Resistance

                                  Mayo Clinic Proceedings: Innovations, Quality & Outcomes
                                  Vol. 4Issue 5p601–607Published online: August 19, 2020
                                  • Jack R. Andrews
                                  • Mohamed E. Ahmed
                                  • Giovanni Motterle
                                  • Sam T. Albadri
                                  • Rimki Haloi
                                  • R. Jeffrey Karnes
                                  • and others
                                  Cited in Scopus: 0
                                  • Preview Hide Preview
                                  • Download PDF
                                  • Export Citation
                                    A 62-year-old man presented with a rising serum concentration of prostate-specific antigen (PSA) to 53.3 ng/mL (to convert to μg/L, multiply by 1) and a PSA doubling time of 2.6 months. Computed tomography, fluorodeoxyglucose–positron emission tomography, and C-11 choline positron emission tomography demonstrated a parotid mass with innumerable lytic bone lesions and diffuse metastatic disease to the neck and mediastinal lymph nodes. Mediastinal lymph node biopsy revealed salivary ductal adenocarcinoma that produced PSA and demonstrated androgen receptor sensitivity.
                                    A Rare Case of Prostate-Specific Antigen–Producing Metastatic Parotid Adenocarcinoma Developing Androgen Receptor Resistance
                                  • Case report
                                    Open Access

                                    Acute Herpes Zoster Radiculopathy of the Lower Extremity With Dermatomal Rash and Lumbar Nerve Enhancement on MRI

                                    Mayo Clinic Proceedings: Innovations, Quality & Outcomes
                                    Vol. 4Issue 5p608–610Published online: August 19, 2020
                                    • Samay Bhushan
                                    • Lisette Dominguez
                                    • Ehsan Shirazi
                                    • Vivek Gupta
                                    Cited in Scopus: 0
                                    • Preview Hide Preview
                                    • Download PDF
                                    • Export Citation
                                      Herpes zoster is a frequent cause of neuralgia and dermatomal vesicular rash secondary to reactivation of latent varicella zoster virus. However, it rarely presents with acute lumbar radiculopathy and the diagnosis can be quite challenging in such cases. Nerve signal abnormalities on magnetic resonance imaging are well recognized in herpes zoster neuropathy or plexopathy affecting the extremities, although gadolinium enhancement is characteristically absent. In this article, we describe a case of acute herpes zoster lumbosacral radiculopathy with characteristic vesicular dermatomal rash and second ever reported finding of gadolinium enhancement of the lumbar nerve on magnetic resonance imaging.
                                      Acute Herpes Zoster Radiculopathy of the Lower Extremity With Dermatomal Rash and Lumbar Nerve Enhancement on MRI
                                    • Case report
                                      Open Access

                                      The Many Faces of Itraconazole Cardiac Toxicity

                                      Mayo Clinic Proceedings: Innovations, Quality & Outcomes
                                      Vol. 4Issue 5p588–594Published online: August 15, 2020
                                      • Hilary R. Teaford
                                      • Omar M. Abu Saleh
                                      • Hector R. Villarraga
                                      • Mark J. Enzler
                                      • Christina G. Rivera
                                      Cited in Scopus: 0
                                      • Preview Hide Preview
                                      • Download PDF
                                      • Export Citation
                                        Itraconazole is well known for carrying a black-box warning for new or worsening congestive heart failure. Single cases of other cardiac- and fluid-related disturbances have been reported periodically since its issuance. We describe a large cohort of patients on itraconazole experiencing a breadth of cardiac- and fluid-related toxicities, ranging from new-onset hypertension to cardiac arrest. A retrospective, single-center, large case series at a large tertiary medical center was conducted. Patients with itraconazole and cardiac toxicity—including hypertension, cardiomyopathy, reduced ejection fraction, and edema—in medical record between January 1, 1999, and May 21, 2019, were identified and assigned a Naranjo score; 31 patients were included with a Naranjo score of 5 or higher.
                                      • Case report
                                        Open Access

                                        Magnetic Resonance Imaging–Guided Focused Ultrasound Ablation of Lumbar Facet Joints of a Patient With a Magnetic Resonance Image Non-Conditional Pacemaker at 1.5T

                                        Mayo Clinic Proceedings: Innovations, Quality & Outcomes
                                        Vol. 4Issue 4p464–468Published in issue: August, 2020
                                        • Jacinta E. Browne
                                        • Christin A. Tiegs-Heiden
                                        • Vance T. Lehman
                                        • Zaiyang Long
                                        • Nicholas J. Hangiandreou
                                        • Robert E. Watson
                                        • and others
                                        Cited in Scopus: 0
                                        • Preview Hide Preview
                                        • Download PDF
                                        • Export Citation
                                          To provide an initial report that patients with magnetic resonance imaging (MRI) non-conditional cardiac implanted electronic device (CIED) can undergo state-of-the-art magnetic resonance imaging–guided focused (MRgFUS) ablation procedures with careful planning and integration of the procedure into an established CIED MRI practice.
                                          Magnetic Resonance Imaging–Guided Focused Ultrasound Ablation of Lumbar Facet Joints of a Patient With a Magnetic Resonance Image Non-Conditional Pacemaker at 1.5T
                                        • Case report
                                          Open Access

                                          Mobile Mitral and Aortic Valvular Masses in Patients With Hereditary Hemorrhagic Telangiectasia Receiving Intravenous Bevacizumab

                                          Mayo Clinic Proceedings: Innovations, Quality & Outcomes
                                          Vol. 4Issue 4p460–463Published online: May 10, 2020
                                          • Hasan Ahmad Albitar
                                          • Yahya Almodallal
                                          • Rick Nishimura
                                          • Vivek N. Iyer
                                          Cited in Scopus: 0
                                          • Preview Hide Preview
                                          • Download PDF
                                          • Export Citation
                                            Bevacizumab is now an emerging treatment option for severe hereditary hemorrhagic telangiectasia–related bleeding including epistaxis and gastrointestinal tract bleeding. The impact of long-term intravenous bevacizumab therapy on cardiac structure and function is unknown. We describe 3 patients receiving intravenous bevacizumab therapy for severe hereditary hemorrhagic telangiectasia–related bleeding who were found to have abnormal mobile masses on the mitral valve (n=2) and aortic valve (n=1). The clinical impact of these findings is unknown and requires further study.
                                            Mobile Mitral and Aortic Valvular Masses in Patients With Hereditary Hemorrhagic Telangiectasia Receiving Intravenous Bevacizumab
                                          • Case report
                                            Open Access

                                            Migratory Polyarthralgias and Skin Rash: Rat Bite Fever with a Positive Anti–Cyclic Citrullinated Peptide

                                            Mayo Clinic Proceedings: Innovations, Quality & Outcomes
                                            Vol. 4Issue 2p223–227Published online: March 9, 2020
                                            • Ilya Y. Shadrin
                                            • Hasan Ahmad Hasan Albitar
                                            • Ana Catarina Paim
                                            • Meltiady Issa
                                            • Walter R. Wilson
                                            Cited in Scopus: 0
                                            • Preview Hide Preview
                                            • Download PDF
                                            • Export Citation
                                              Rat bite fever is a rare, underdiagnosed disease caused by Streptobacillus moniliformis in the United States, and is typically characterized by leukocytosis, elevated C-reactive protein, migratory polyarthralgias, and pustular skin rash. Rat bite fever is frequently misdiagnosed as either a viral illness or a rheumatologic disease and carries a high mortality risk if untreated. We report the first case of rat bite fever associated with positive anti–cyclic citrullinated peptide. The patient initially presented with low back pain and developed a pustular rash as well as severe asymmetric polyarthralgias.
                                              Migratory Polyarthralgias and Skin Rash
                                            • Case report
                                              Open Access

                                              Approaching Acute Vertigo With Diplopia: A Rare Skew Deviation in Vestibular Neuritis

                                              Mayo Clinic Proceedings: Innovations, Quality & Outcomes
                                              Vol. 4Issue 2p216–222Published online: March 9, 2020
                                              • Scott D.Z. Eggers
                                              • Jorge C. Kattah
                                              Cited in Scopus: 0
                                              Supplementary Materials
                                              • Preview Hide Preview
                                              • Download PDF
                                              • Export Citation
                                              • Video
                                              Evaluating the patient with acute constant vertigo or diplopia can be a daunting task for clinicians, who recognize that such symptoms can be the manifestation of potentially devastating disorders like stroke but may be uncomfortable eliciting and interpreting the key symptoms and subtle signs that distinguish dangerous from benign causes. We present a novel and highly instructive case of a patient with acute vertigo and binocular diplopia from a large skew deviation due to vestibular neuritis. As the case unfolds, text and video commentary guide the clinician through the important elements of the history, bedside examination, and laboratory evaluation necessary for accurate diagnosis in the acute vestibular syndrome.
                                              Approaching Acute Vertigo With Diplopia: A Rare Skew Deviation in Vestibular Neuritis
                                            • Case report
                                              Open Access

                                              Removal of a Large Stone in the Upper Thoracic Esophagus

                                              Mayo Clinic Proceedings: Innovations, Quality & Outcomes
                                              Vol. 4Issue 1p105–108Published online: January 13, 2020
                                              • Patricia V. Hernandez
                                              • Diana L. Snyder
                                              • Saba Ghorab
                                              • Neej J. Patel
                                              • Michael L. Hinni
                                              • Jennifer L. Horsley-Silva
                                              Cited in Scopus: 0
                                              • Preview Hide Preview
                                              • Download PDF
                                              • Export Citation
                                                Ingestion of a foreign body is a common occurrence. Flexible endoscopy is most commonly used for treatment, but certain large foreign bodies are more easily retrieved with rigid endoscopy. We present a technically challenging case of intentional ingestion of a large stone that required retrieval from the upper thoracic esophagus using rigid endoscopy. This case highlights the importance of alternative methods to manage large foreign bodies and of collaboration of medical subspecialties.
                                                Removal of a Large Stone in the Upper Thoracic Esophagus
                                              • Case report
                                                Open Access

                                                Improved Treatment Response Following Magnetic Resonance Imaging–Guided Focused Ultrasound for Lumbar Facet Joint Pain

                                                Mayo Clinic Proceedings: Innovations, Quality & Outcomes
                                                Vol. 4Issue 1p109–113Published online: December 28, 2019
                                                • Christin A. Tiegs-Heiden
                                                • Vance T. Lehman
                                                • Krzysztof R. Gorny
                                                • Andrea J. Boon
                                                • Gina K. Hesley
                                                Cited in Scopus: 0
                                                • Preview Hide Preview
                                                • Download PDF
                                                • Export Citation
                                                  Magnetic resonance imaging–guided focused ultrasound (MRgFUS) is a noninvasive modality that allows for precise tissue ablation with sparing of surrounding structures. Early reports of the use of MRgFUS for the treatment of facet joint osteoarthritis are promising. We present a case of facet joint pain treated successfully by MRgFUS at our institution. Magnetic resonance imaging–guided focused ultrasonography may be a useful modality for patients with facet joint–mediated low back pain, particularly in the setting of limited or refractory response to conventional treatments.
                                                  Improved Treatment Response Following Magnetic Resonance Imaging–Guided Focused Ultrasound for Lumbar Facet Joint Pain
                                                • Case report
                                                  Open Access

                                                  Rebound Vertebral Fractures in a Patient With Lung Cancer After Oncology-Dose Denosumab Discontinuation: A Cautionary Tale

                                                  Mayo Clinic Proceedings: Innovations, Quality & Outcomes
                                                  Vol. 3Issue 2p235–237Published in issue: June, 2019
                                                  • Alexander Tyan
                                                  • Sandip Pravin Patel
                                                  • Shanna Block
                                                  • Tudor Hughes
                                                  • Karen C. McCowen
                                                  Cited in Scopus: 0
                                                  • Preview Hide Preview
                                                  • Download PDF
                                                  • Export Citation
                                                    We describe a 55-year-old woman with lung cancer complicated by bone metastases. Treatment with denosumab (120 mg monthly) was interrupted after 9 doses because of concern for potential osteonecrosis of the jaw during upcoming dental work. Fifteen months after receiving the last dose of denosumab, the patient presented with 7 atraumatic spinal compression fractures requiring kyphoplasty for symptom relief. No malignancy was found in pathology specimens. Evaluation for secondary causes of osteoporosis was negative.
                                                    Rebound Vertebral Fractures in a Patient With Lung Cancer After Oncology-Dose Denosumab Discontinuation: A Cautionary Tale
                                                  • Case report
                                                    Open Access

                                                    Thiamine and Heart Failure: Challenging Cases of Modern-Day Cardiac Beriberi

                                                    Mayo Clinic Proceedings: Innovations, Quality & Outcomes
                                                    Vol. 3Issue 2p221–225Published in issue: June, 2019
                                                    • Jonathan Helali
                                                    • Sandy Park
                                                    • Boback Ziaeian
                                                    • Janet K. Han
                                                    • Azadeh Lankarani-Fard
                                                    Cited in Scopus: 0
                                                    • Preview Hide Preview
                                                    • Download PDF
                                                    • Export Citation
                                                      Cardiac beriberi, or heart failure due to thiamine deficiency, is considered rare in the developed world. The diagnosis is often only considered in limited populations such as those with chronic alcoholism. Alternatively, the disease can be mislabeled as “alcoholic cardiomyopathy” or “nonischemic cardiomyopathy.” The following 2 cases illustrate the need to expand our vigilance to other at-risk populations.
                                                      Thiamine and Heart Failure
                                                    • Case report
                                                      Open Access

                                                      Persistent Exertional Chest Pain in a Marathon Runner: Exercise-induced, Painful, Left Bundle Branch Block Syndrome Treated With His-Bundle Pacing

                                                      Mayo Clinic Proceedings: Innovations, Quality & Outcomes
                                                      Vol. 3Issue 2p226–230Published in issue: June, 2019
                                                      • Olubunmi O. Oladunjoye
                                                      • Adeolu O. Oladunjoye
                                                      • Oreoluwa Oladiran
                                                      • David J. Callans
                                                      • Robert D. Schaller
                                                      • Anthony Licata
                                                      Cited in Scopus: 0
                                                      • Preview Hide Preview
                                                      • Download PDF
                                                      • Export Citation
                                                        A 49-year-old woman presented with exercise-induced chest discomfort during long-distance running that was occasionally present during rest. Significant coronary artery disease was excluded and a diagnosis of “painful left bundle branch block (LBBB) syndrome” was made after correlation of LBBB aberrancy with symptoms during Holter monitoring. The patient underwent confirmatory testing consisting of rapid atrial pacing below and above 130 beats per minute, the rate cut-off for LBBB manifestation.
                                                        Persistent Exertional Chest Pain in a Marathon Runner: Exercise-induced, Painful, Left Bundle Branch Block Syndrome Treated With His-Bundle Pacing
                                                      • Case report
                                                        Open Access

                                                        Esophageal Stricture Following Radiation, Concurrent Immunochemotherapy, Treated With Hyperbaric Oxygen and Dilation

                                                        Mayo Clinic Proceedings: Innovations, Quality & Outcomes
                                                        Vol. 3Issue 2p241–245Published in issue: June, 2019
                                                        • Olayinka D. Ajayi
                                                        • Cadman L. Leggett
                                                        • Sarel J. Myburgh
                                                        • Stephen M. Hendriksen
                                                        • Christopher J. Logue
                                                        • Joseph W. Walter
                                                        • and others
                                                        Cited in Scopus: 0
                                                        • Preview Hide Preview
                                                        • Download PDF
                                                        • Export Citation
                                                          Low-dose palliative radiation may offer symptomatic relief in patients with spinal metastases from primary renal cell cancer and is unlikely to result in radiation injury. Patients with advanced malignancy requiring palliative radiation are often also receiving chemotherapy. Synergistic adverse effects resulting from combined palliative radiation and novel antiprogrammed cell death-1 (anti-PD 1) and/or multityrosine kinase inhibitors are rare. We report about a 60-year-old woman with metastatic clear-cell renal cancer, status post-left nephrectomy, with debilitating mid-back pain from metastatic tumor burden and foraminal nerve compression.
                                                          Esophageal Stricture Following Radiation, Concurrent Immunochemotherapy, Treated With Hyperbaric Oxygen and Dilation
                                                        • Case report
                                                          Open Access

                                                          Coronary Spasm and Polymorphic Ventricular Tachycardia One Year After Takotsubo

                                                          Mayo Clinic Proceedings: Innovations, Quality & Outcomes
                                                          Vol. 3Issue 2p231–234Published online: May 5, 2019
                                                          • Noah N. Williford
                                                          • Alexander Mazur
                                                          • Troy Rhodes
                                                          • Elaine Demetroulis
                                                          • Milena A. Gebska
                                                          Cited in Scopus: 0
                                                          • Preview Hide Preview
                                                          • Download PDF
                                                          • Export Citation
                                                            Stress cardiomyopathy is typically considered to be a disease with a favorable long-term prognosis, with malignant arrhythmias accompanying only the acute phase. We describe a 51-year-old female who presented with palpitations one year after stress cardiomyopathy and complete recovery of apical left ventricular wall motion. Coronary spasm was strongly suspected based on transient ST-segment elevations followed by sustained polymorphic ventricular tachycardia captured on ambulatory Holter. Contrast injection during coronary angiography reproduced spasm and ventricular arrhythmia that resolved with intracoronary nitroglycerine.
                                                            Coronary Spasm and Polymorphic Ventricular Tachycardia One Year After Takotsubo
                                                          • Case report
                                                            Open Access

                                                            A Novel Diagnostic Approach for Suspected Icodextrin Pleural Effusion in a Peritoneal Dialysis Patient

                                                            Mayo Clinic Proceedings: Innovations, Quality & Outcomes
                                                            Vol. 3Issue 2p238–240Published online: May 5, 2019
                                                            • Macaulay Amechi Chukwukadibia Onuigbo
                                                            • Nneoma Agbasi
                                                            • Kramer Wahlberg
                                                            • Bibek Karki
                                                            • Sana Khan
                                                            Cited in Scopus: 0
                                                            • Preview Hide Preview
                                                            • Download PDF
                                                            • Export Citation
                                                              Symptomatic pleural effusion secondary to pleuroperitoneal communication in patients undergoing peritoneal dialysis (PD) occurs in approximately 2% of patients undergoing continuous ambulatory PD. The classic presentation is that of a low-protein, high-glucose pleural aspirate consistent with the high dextrose concentrations present in standard PD fluids, hence the name sweet hydrothorax. Nevertheless, the increasing use of icodextrin calls for an innovative bedside diagnostic approach because icodextrin does not contain high concentrations of dextrose after all.
                                                              A Novel Diagnostic Approach for Suspected Icodextrin Pleural Effusion in a Peritoneal Dialysis Patient
                                                            • Case report
                                                              Open Access

                                                              Confirmed Efficacy of Lenalidomide and Dexamethasone in Unresectable Cutaneous Facial Rosai-Dorfman-Destombes Disease

                                                              Mayo Clinic Proceedings: Innovations, Quality & Outcomes
                                                              Vol. 3Issue 1p94–96Published online: January 18, 2019
                                                              • Mae S. Al-Ghawas
                                                              • Tony Ng
                                                              • Luke Y.C. Chen
                                                              Cited in Scopus: 0
                                                              • Preview Hide Preview
                                                              • Download PDF
                                                              • Export Citation
                                                                Rosai-Dorfman-Destombes disease is a rare nonmalignant histiocytic condition. Cutaneous disease is common and typically treated with surgical resection, but the optimal medical therapy for inoperable disease has not been determined. We present a 30-year-old man with a large unresectable cutaneous facial mass refractory to corticosteroids and rituximab. He had an excellent response to 13 cycles of lenalidomide 15 mg for 21 out of 28 day cycles and dexamethasone 40 mg/wk with no adverse effects. This is the second case of Rosai-Dorfman-Destombes disease in the literature responsive to lenalidomide-based therapy and confirms the potential efficacy of an immunomodulatory regimen in this disease.
                                                                Confirmed Efficacy of Lenalidomide and Dexamethasone in Unresectable Cutaneous Facial Rosai-Dorfman-Destombes Disease
                                                              • Case report
                                                                Open Access

                                                                Adult Intestinal Botulism: A Rare Presentation in an Immunocompromised Patient With Short Bowel Syndrome

                                                                Mayo Clinic Proceedings: Innovations, Quality & Outcomes
                                                                Vol. 2Issue 3p291–296Published online: August 3, 2018
                                                                • Pramod K. Guru
                                                                • Tara L. Becker
                                                                • Alana Stephens
                                                                • Rocco J. Cannistraro
                                                                • Benjamin H. Eidelman
                                                                • D. Jane Hata
                                                                • and others
                                                                Cited in Scopus: 0
                                                                • Preview Hide Preview
                                                                • Download PDF
                                                                • Export Citation
                                                                  The cholinergic heat-labile neurotoxin produced by Clostridium species is primarily responsible for the clinical manifestations of botulism. The classic phenotypic presentation of botulism consists of subacute descending flaccid paralysis with intact sensory function. Traditionally, it is classified into 3 main forms (foodborne, wound-related, and infantile) on the basis of primary site of toxin entry into the human nervous system. Toxemia is the common pathophysiology in all forms of botulism. Adult intestinal toxemia botulism is an extremely rare form of the disease with pathogenesis similar to that of infant-type botulism.
                                                                • Case report
                                                                  Open Access

                                                                  Dabrafenib and Trametinib Treatment for Erdheim-Chester Disease With Brain Stem Involvement

                                                                  Mayo Clinic Proceedings: Innovations, Quality & Outcomes
                                                                  Vol. 2Issue 3p303–308Published online: July 4, 2018
                                                                  • Ahmed Al Bayati
                                                                  • Thomas Plate
                                                                  • Mahmood Al Bayati
                                                                  • Yaohong Yan
                                                                  • Efrat Saraf Lavi
                                                                  • Joseph D. Rosenblatt
                                                                  Cited in Scopus: 0
                                                                  Supplementary Materials
                                                                  • Preview Hide Preview
                                                                  • Download PDF
                                                                  • Export Citation
                                                                    Erdheim-Chester disease (ECD) is a rare form of non–Langerhans cell histiocytosis characterized by infiltration of organs by CD68+ and CD1a− lipid-laden histiocytes, including the central nervous system in more than a third of patients. Molecular analysis of ECD samples has demonstrated the prevalence of BRAF V600E mutations as high as 54%. Recently, vemurafenib became the only Food and Drug Administration–approved treatment for patients with ECD who carry the BRAF V600E mutation. However, dabrafenib has been suggested to have greater brain distribution.
                                                                    Dabrafenib and Trametinib Treatment for Erdheim-Chester Disease With Brain Stem Involvement
                                                                  • Case report
                                                                    Open Access

                                                                    Successful Renal Outcome in Membranoproliferative Glomerulonephritis Following Treatment of the Underlying Subtle Clone: A Case Report

                                                                    Mayo Clinic Proceedings: Innovations, Quality & Outcomes
                                                                    Vol. 2Issue 3p297–302Published online: June 5, 2018
                                                                    • Ritika Rana
                                                                    • Paul Cockwell
                                                                    • Bindu Vydianath
                                                                    • Mark Cook
                                                                    • Guy Pratt
                                                                    • Mark Trehane Drayson
                                                                    • and others
                                                                    Cited in Scopus: 0
                                                                    • Preview Hide Preview
                                                                    • Download PDF
                                                                    • Export Citation
                                                                      Membranoproliferative glomerulonephritis (MPGN) secondary to a monoclonal gammopathy is a rare glomerular disease and is defined as a monoclonal gammopathy of renal significance. The disease is characterized by glomerular monotypic immunoglobulin deposits and specific changes on light microscopy and electron microscopy. Immunochemistry is required to establish monoclonality, and electron microscopy helps to characterize the deposits ultrastructurally. Investigation for the underlying monoclonal protein should be done.
                                                                      Successful Renal Outcome in Membranoproliferative Glomerulonephritis Following Treatment of the Underlying Subtle Clone: A Case Report
                                                                    • Case report
                                                                      Open Access

                                                                      Association of Immune-Mediated Cerebellitis With Immune Checkpoint Inhibitor Therapy

                                                                      Mayo Clinic Proceedings: Innovations, Quality & Outcomes
                                                                      Vol. 2Issue 1p74–77Published online: February 4, 2018
                                                                      • Joanna Zurko
                                                                      • Amitkumar Mehta
                                                                      Cited in Scopus: 0
                                                                      Supplementary Materials
                                                                      • Preview Hide Preview
                                                                      • Download PDF
                                                                      • Export Citation
                                                                        Immune-mediated encephalitis related to immune checkpoint inhibitor therapy is a rare but increasingly described condition that can cause significant morbidity. There are several reported cases in the literature but no previously described cases of immune-mediated cerebellitis. We describe a case of acute cerebellitis that developed in a 20-year-old man with primary refractory Hodgkin lymphoma being treated with the immune checkpoint inhibitor nivolumab. After exposure to 3 cycles of nivolumab, the patient had acute onset of headache, ataxia, nausea, and vomiting, with imaging findings of cerebellar edema, early tonsillar herniation, and early hydrocephalus.
                                                                        Association of Immune-Mediated Cerebellitis With Immune Checkpoint Inhibitor Therapy
                                                                      • Case report
                                                                        Open Access

                                                                        Brachial Plexus Neuritis Associated With Anti–Programmed Cell Death-1 Antibodies: Report of 2 Cases

                                                                        Mayo Clinic Proceedings: Innovations, Quality & Outcomes
                                                                        Vol. 1Issue 2p192–197Published in issue: September, 2017
                                                                        • Reem M. Alhammad
                                                                        • Roxanna S. Dronca
                                                                        • Lisa A. Kottschade
                                                                        • Heidi J. Turner
                                                                        • Nathan P. Staff
                                                                        • Michelle L. Mauermann
                                                                        • and others
                                                                        Cited in Scopus: 0
                                                                        • Preview Hide Preview
                                                                        • Download PDF
                                                                        • Export Citation
                                                                          Recently, guidelines have been outlined for management of immune-related adverse events occurring with immune checkpoint inhibitors in cancer, irrespective of affected organ systems. Increasingly, these complications have been recognized as including diverse neuromuscular presentations, such as demyelinating and axonal length–dependent peripheral neuropathies, vasculitic neuropathy, myasthenia gravis, and myopathy. We present 2 cases of brachial plexopathy developing on anti–programmed cell death-1 checkpoint inhibitor therapies (pembrolizumab, nivolumab).
                                                                          Brachial Plexus Neuritis Associated With Anti–Programmed Cell Death-1 Antibodies: Report of 2 Cases
                                                                        • Case report
                                                                          Open Access

                                                                          Achalasia in a Patient Undergoing Hematologic Stem Cell Transplant After Exposure to Tacrolimus

                                                                          Mayo Clinic Proceedings: Innovations, Quality & Outcomes
                                                                          Vol. 1Issue 2p198–201Published online: August 2, 2017
                                                                          • Sencer Goklemez
                                                                          • Lauren M. Curtis
                                                                          • Alao Hawwa
                                                                          • Alexander Ling
                                                                          • Daniele Avila
                                                                          • Theo Heller
                                                                          • and others
                                                                          Cited in Scopus: 0
                                                                          • Preview Hide Preview
                                                                          • Download PDF
                                                                          • Export Citation
                                                                            Calcineurin inhibitors (CNIs) are effective agents used for prevention of graft-vs-host disease after allogeneic hematopoietic stem cell transplant or for organ rejection in solid-organ transplant. However, CNIs have a wide range of adverse effects that may necessitate changing to another CNI or immunosuppressive agent. We report a case of acute myeloid leukemia in which achalasia developed after exposure to tacrolimus, as revealed by esophagram results. The patient's symptoms and signs were ameliorated after a change to cyclosporine.
                                                                            Achalasia in a Patient Undergoing Hematologic Stem Cell Transplant After Exposure to Tacrolimus
                                                                          • Case report
                                                                            Open Access

                                                                            Cell-Based Therapy for Myocardial Dysfunction After Fontan Operation in Hypoplastic Left Heart Syndrome

                                                                            Mayo Clinic Proceedings: Innovations, Quality & Outcomes
                                                                            Vol. 1Issue 2p185–191Published online: August 2, 2017
                                                                            • Muhammad Y. Qureshi
                                                                            • Allison K. Cabalka
                                                                            • Shakila P. Khan
                                                                            • Donald J. Hagler
                                                                            • Dawit T. Haile
                                                                            • Bryan C. Cannon
                                                                            • and others
                                                                            Cited in Scopus: 0
                                                                            • Preview Hide Preview
                                                                            • Download PDF
                                                                            • Export Citation
                                                                              Myocardial dysfunction after Fontan palliation for univentricular congenital heart disease is a challenging clinical problem. The medical treatment has a limited impact, with cardiac transplant being the ultimate management step. Cell-based therapies are evolving as a new treatment for heart failure. Phase 1 clinical trials using regenerative therapeutic strategies in congenital heart disease are ongoing. We report the first case of autologous bone marrow–derived mononuclear cell administration for ventricular dysfunction, 23 years after Fontan operation in a patient with hypoplastic left heart syndrome.
                                                                            • Case report
                                                                              Open Access

                                                                              A Rare STRN-ALK Fusion in Lung Adenocarcinoma Identified Using Next-Generation Sequencing–Based Circulating Tumor DNA Profiling Exhibits Excellent Response to Crizotinib

                                                                              Mayo Clinic Proceedings: Innovations, Quality & Outcomes
                                                                              Vol. 1Issue 1p111–116Published online: April 27, 2017
                                                                              • Yan Yang
                                                                              • Shu-Kui Qin
                                                                              • Jian Zhu
                                                                              • Rui Wang
                                                                              • Yu-Mei Li
                                                                              • Zong-Yu Xie
                                                                              • and others
                                                                              Cited in Scopus: 0
                                                                              • Preview Hide Preview
                                                                              • Download PDF
                                                                              • Export Citation
                                                                                The ALK gene fusion has been identified as a new driver gene in non–small cell lung cancer (NSCLC). It includes the EML4-ALK rearrangement as a recurring event that renders the tumor sensitive to ALK tyrosine kinase inhibitor crizotinib. In addition, several other fusion partners to ALK kinase domain (eg, TFG, KLC1, and KIF5B) have been identified in NSCLC. However, clinical data relevant to response in lung cancer harboring these rare ALK translocations are not fully available. A nonsmoking Chinese male originally diagnosed with “stage Ib lung adenocarcinoma” showed metastases in regional lymph nodes, pleura, and bone 1 year after surgery.
                                                                                A Rare STRN-ALK Fusion in Lung Adenocarcinoma Identified Using Next-Generation Sequencing–Based Circulating Tumor DNA Profiling Exhibits Excellent Response to Crizotinib
                                                                              Page 1 of 1
                                                                              • Home
                                                                              • Articles & Issues
                                                                              • COVID Articles in Press
                                                                              • Issue In Progress
                                                                              • Current Issue
                                                                              • List of Issues
                                                                              • Visual and Interactive
                                                                              • Author Interview Video Library
                                                                              • Collections
                                                                              • Case Reports
                                                                              • Commentaries
                                                                              • Editorials
                                                                              • For Authors
                                                                              • Submit a Manuscript
                                                                              • Author Information
                                                                              • Open Access Options
                                                                              • Permissions
                                                                              • Researcher Academy
                                                                              • Journal Info
                                                                              • About the Journal
                                                                              • Contact Editorial Office
                                                                              • Editorial Board
                                                                              • Reprints
                                                                              • New Content Alerts
                                                                              • Companion Titles
                                                                              • Mayo Clinic Proceedings
                                                                              • MCP: Digital Health
                                                                              • Mayo Clinic
                                                                              • Home
                                                                              • Mayo Clinic Resources
                                                                              • Online Services for Medical Professionals
                                                                              • Continuing Medical Education
                                                                              • Follow Us
                                                                              • YouTube
                                                                              • Twitter

                                                                              The content on this site is intended for healthcare professionals.



                                                                              We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
                                                                              Copyright © 2023 Elsevier Inc. except certain content provided by third parties.

                                                                              • Privacy Policy  
                                                                              • Terms and Conditions  
                                                                              • Accessibility  
                                                                              • Help & Contact

                                                                              RELX